Literature DB >> 9494779

Cancer and bone.

T A Guise1, G R Mundy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9494779     DOI： 10.1210/edrv.19.1.0323

Source DB:  PubMed          Journal:  Endocr Rev        ISSN： 0163-769X            Impact factor:   19.871


× No keyword cloud information.
  103 in total

1.  RANK is essential for osteoclast and lymph node development.

Authors:  W C Dougall; M Glaccum; K Charrier; K Rohrbach; K Brasel; T De Smedt; E Daro; J Smith; M E Tometsko; C R Maliszewski; A Armstrong; V Shen; S Bain; D Cosman; D Anderson; P J Morrissey; J J Peschon; J Schuh
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

2.  Interactions between immune and bone cells: new insights with many remaining questions.

Authors:  J Lorenzo
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 3.  Targeting osseous metastases: rationale and development of radio-immunotherapy for prostate cancer.

Authors:  Michael J Morris; Neeta Pandit-Taskar; Chaitanya Divgi; Steven Larson; Howard I Scher
Journal:  Curr Oncol Rep       Date:  2004-05       Impact factor: 5.075

4.  Cytotoxic effect of clodronate and zoledronate on the chondrosarcoma cell lines HTB-94 and CAL-78.

Authors:  Arne Streitbuerger; Marcel Henrichs; Helmut Ahrens; Claudia Lanvers-Kaminzky; Francois Gouin; Georg Gosheger; Jendrik Hardes
Journal:  Int Orthop       Date:  2010-10-02       Impact factor: 3.075

5.  Metastatic breast cancer cells suppress osteoblast adhesion and differentiation.

Authors:  Robyn R Mercer; Chiaki Miyasaka; Andrea M Mastro
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

6.  CT-based handling and analysis of preclinical multimodality imaging data of bone metastases.

Authors:  Thomas J A Snoeks; Martin Baiker; Eric L Kaijzel; Boudewijn P F Lelieveldt; Clemens W G M Löwik
Journal:  Bonekey Rep       Date:  2012-05-09

7.  Interaction between bone marrow stromal cells and neuroblastoma cells leads to a VEGFA-mediated osteoblastogenesis.

Authors:  Josephine H HaDuong; Laurence Blavier; Sanjeev K Baniwal; Baruch Frenkel; Jemily Malvar; Vasu Punj; Richard Sposto; Yves A DeClerck
Journal:  Int J Cancer       Date:  2015-02-21       Impact factor: 7.396

Review 8.  [Introduction to bisphosphonates. History and functional mechanisms].

Authors:  H Fleisch
Journal:  Orthopade       Date:  2007-02       Impact factor: 1.087

9.  Managing bone loss and bone metastases in prostate cancer patients: a focus on bisphosphonate therapy.

Authors:  Ron S Israeli
Journal:  Rev Urol       Date:  2008

Review 10.  Zoledronic acid in genitourinary cancer.

Authors:  M A Climent; U Anido; M J Méndez-Vidal; J Puente
Journal:  Clin Transl Oncol       Date:  2013-04-25       Impact factor: 3.405
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.